Endotoxin, a lipopolysaccharide (LPS), has for many years been recognized a
s a key effector molecule in the pathogenesis of Gram-negative sepsis and s
eptic shock. Seven strains of the Bacteroides fragilis group were studied f
or their ability to liberate endotoxin upon exposure to five anti-anaerobic
antibiotics, trovafloxacin, cefoxitin, imipenem, meropenem and piperacilli
n/tazobactam, in an in-vitro experiment. The minimum inhibitory concentrati
ons (MICs) of the antibiotics were determined by using the broth macrodilut
ion technique. Thereafter, endotoxin liberation was detected in the filtere
d broth cultures of the anaerobic bacteria by the limulus amebocyte lysate
(LAL) assay after exposing the organisms to four different concentrations o
f the antibiotics in supplemented Brucella broth. Aliquots of the broth cul
tures were also taken at intervals of 0, 6, 24 and 48 h for viable counts.
All seven Gram-negative anaerobic bacteria investigated liberated induced c
ell-free endotoxin in filtered broth culture many times higher than the con
trol. There was noticeable variation in the propensity of some antibiotics
to induce endotoxin liberation. At four times the MICs, cefoxitin and piper
acillin/tazobactam induced negligible quantities of endotoxin after 48 h ex
posure, whereas the others induced high levels of endotoxin release. After
exposure to all concentrations for 48 h, endotoxin activity in the test sys
tem was many times higher with the Bacteroides fragilis sensu stricto than
with the rest of the species in the Bacteroides group. To varying degrees,
all five antibiotics had the capacity to induce endotoxin liberation by Gra
m-negative anaerobic bacteria. This differential endotoxin release by the B
. fragilis group may, in part, explain why B, fragilis sensu stricto, more
than the other Bacteroides spp,, is usually associated with clinical infect
ions and higher morbidity.